Serologic characteristics of oxaliplatin antibodies in 15 patients with drug‐induced immune hemolytic anemia
Author:
Affiliation:
1. Etablissement Français du Sang, Laboratoire de Biologie Médicale, Site Saint‐Antoine Paris France
2. Etablissement Français du Sang, Laboratoire de Biologie Médicale Site Ivry, 122‐130 rue Marcel Hartmann 94200 Ivry‐sur‐Seine France
Publisher
Wiley
Subject
Hematology,Immunology,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16360
Reference18 articles.
1. Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2. Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
3. Acute oxaliplatin‐induced hemolytic anemia, thrombocytopenia and renal failure: Case report and literature review;Phull P;Clin Colorectal Cancer,2016
4. Oxaliplatin-induced haemolytic anaemia
5. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cytokine profiling, pretreatment with anakinra, and tolerance development in platinum-induced mixed hypersensitivity reactions;Annals of Allergy, Asthma & Immunology;2023-10
2. Piperacillin-tazobactam induced immune hemolytic anemia led to increased renal impairment and eventual death from multiple organ failure in a patient with hypertensive nephropathy: case report and literature review;BMC Nephrology;2023-06-14
3. Case report: A rare case of acute hemolysis in advanced rectal cancer after XELOX and nivolumab treatment: analysis of drug-dependent antibodies;Frontiers in Medicine;2023-05-25
4. Case report: First case of pemetrexed plus cisplatin-induced immune hemolytic anemia in a patient with lung adenocarcinoma;Frontiers in Medicine;2022-08-25
5. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption;Frontiers in Immunology;2021-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3